Experience with all Phase I study designs and protocols, including:
Proof of Principle/ Proof of Concept
*Single Ascending Dose (SAD)
*Multiple Ascending Dose (MAD)
*Maximum Tolerated Dose (MTD)
*Dose Concentration Effect Relationship
Pharmacokinetic Studies/ Pharmacodynamic Studies (PK/PD)
Drug-Drug & Drug-Food Interactions (DDI/DFI)
Special Populations (including diabetic, hepatic, geriatric, obese, pre- and post-menopausal, renal)
Phase Ib (disease-specific)
For More Information:
Our Medical Director is Padmaja Gayam, MD. Our Business Development Manager is Ben Riedlinger. If you are interested in collaborating or learning more about Wake Research, please use the form below:
Wake Research is home to the Wake Research family of companies, headquartered near Research Triangle Park, North Carolina and servicing surrounding metropolitan areas, including Wake, Johnston, Nash, Durham and Orange Counties, and the cities of Raleigh, Durham, Chapel Hill, Cary, Apex, Holly Springs, Garner, Clayton, Knightdale, Wake Forest, Benson, Creedmoor and beyond.
Wake Research is a unique and innovative resource site for Phase I, Phase II, Phase III and Phase IV clinical trials. We offer a wide variety of trial studies that may be suitable for a diverse pool of qualified individuals including, Cancer, Crohn's Disease, Ulcerative Colitis and Irritable Bowel Syndrome.